Deutsche Bank’s AIM ImmunoTech AIM Stock Holding History

Deutsche Bank’s Portfolio AIM Stock Details AIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-44	Closed	-$2K	–	5232
2019 Q4	$2K	Buy	+44	New	+$2.21K	﹤0.01%	4886
2018 Q4	–	Hold	0	–	–	–	5743
2018 Q3	–	Hold	0	–	–	–	5788
2018 Q1	–	Hold	0	–	–	–	5869
2017 Q4	–	Hold	0	–	–	–	5398
2017 Q3	–	Hold	0	–	–	–	5398
2017 Q2	–	Hold	0	–	–	–	5430
2017 Q1	–	Hold	0	–	–	–	5404
2016 Q4	–	Hold	0	–	–	–	5366
2016 Q3	–	Hold	0	–	–	–	5640
2016 Q2	–	Hold	0	–	–	–	5663
2016 Q1	–	Sell	-1	Closed	-$6K	–	5655
2015 Q4	$6K	Buy	+1	New	+$6.8K	﹤0.01%	5051
2015 Q3	–	Hold	0	–	–	–	5655
2015 Q2	–	Hold	0	–	–	–	5699
2014 Q4	–	Hold	0	–	-$1K	–	6646
2014 Q3	–	Hold	0	–	–	–	5858
2014 Q1	–	Hold	0	–	–	–	6106
2013 Q4	–	Sell	-6	Closed	-$72.5K	–	6192
2013 Q3	$76K	Buy	+6	New	+$75.6K	﹤0.01%	4530
2013 Q2	–	Hold	0	–	–	–	5412

Other funds holding AIM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

TCM

Traynor Capital Management Malvern, Pennsylvania $2.18B AUM 62.36% 1-Year Est. Return

Deutsche Bank's AIM Position: Q1 2020 in Review

Deutsche Bank sold out of AIM ImmunoTech (AIM) in Q1 2020, closing a stake of 44 shares — an estimated $2K sold.

Deutsche Bank first reported a position in AIM in Q3 2013 and held it in 3 quarters. The position peaked at $76K in Q3 2013. 20 funds tracked by Wall St. Rank hold AIM as of Q1 2020.

Deutsche Bank reported no remaining AIM ImmunoTech position as of Q1 2020 after selling out during the quarter.
Deutsche Bank sold 44 AIM ImmunoTech shares in Q1 2020, an estimated $2K.
Deutsche Bank first reported a position in AIM ImmunoTech in Q3 2013 and held it in 3 quarters.
Deutsche Bank's AIM ImmunoTech position peaked at $76K in Q3 2013.
20 funds tracked by Wall St. Rank held AIM ImmunoTech as of Q1 2020.

Based on Deutsche Bank's 13F filing for Q1 2020, filed 14 May 2020.